Intuitive Surgical, Inc. $ISRG Stock: Washington Trust Advisors Inc. Grows Position

Key Points

• Washington Trust Advisors increased its Intuitive Surgical stake by 35% in the third quarter, bringing its holdings to 22,718 shares valued at approximately $9.24 million. Institutional investors collectively own 83.64% of the company.
• Intuitive Surgical reported third-quarter revenue of $3.05 billion, up 21.7% year over year, and earnings per share of $3.00, beating analyst expectations. Wall Street maintains a broadly positive view, with a “Moderate Buy” consensus rating and an average price target of $493.54.
• Key risks include slowing U.S. da Vinci procedure growth and margin pressure from approximately $450 million in antitrust-settlement costs and pricing effects. The stock trades at a premium valuation, with a price-to-earnings ratio of about 54.7.

Washington Trust Advisors Inc. raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 35.0% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 22,718 shares of the medical equipment provider's stock after purchasing an additional 5,887 shares during the period. Washington Trust Advisors Inc.'s holdings in Intuitive Surgical were worth $9,238,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the stock. Main Street Group LTD acquired a new position in shares of Intuitive Surgical in the 1st quarter valued at $30,000. North Point Portfolio Managers Corp OH acquired a new stake in shares of Intuitive Surgical during the 3rd quarter worth $27,000. Compass Wealth Management LLC acquired a new stake in shares of Intuitive Surgical during the 3rd quarter worth $29,000. Evergreen Advisors LLC acquired a new stake in shares of Intuitive Surgical during the 1st quarter worth $35,000. Finally, Compass Financial Management LLC purchased a new position in shares of Intuitive Surgical in the 2nd quarter worth $30,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the company. TD Cowen reiterated a "buy" rating and issued a $485.00 target price on shares of Intuitive Surgical in a report on Monday. KeyCorp reissued an "overweight" rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. BNP Paribas Exane upgraded Intuitive Surgical to an "outperform" rating in a research note on Tuesday, July 28th. HSBC downgraded Intuitive Surgical from a "buy" rating to a "hold" rating and set a $391.00 price objective on the stock. in a report on Thursday, July 30th. Finally, Raymond James Financial reaffirmed an "outperform" rating and issued a $480.00 price objective on shares of Intuitive Surgical in a research note on Wednesday. One analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $493.54.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical reported third-quarter revenue of approximately $3.05 billion, up more than 20% year over year, while earnings exceeded consensus expectations. The company also highlighted continued international expansion and adoption of its robotic-surgery systems. Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story
• Positive Sentiment: Several firms remain constructive: BTIG, Stifel Nicolaus, Piper Sandler, and Oppenheimer reaffirmed or maintained Buy ratings. Baird also raised its price target, while Erste Group upgraded the stock to Buy. ISRG was added to the Zacks Rank #1 Strong Buy list. New Strong Buy Stocks for October 23rd
• Neutral Sentiment: The quarter included roughly $450 million of costs tied to an antitrust settlement, along with pricing-related pressure, which reduced margins. These items appear largely nonrecurring, but investors are assessing their effect on near-term profitability. Intuitive Surgical Reports Q3 2026 Earnings Impacted by $450M Antitrust Settlement
• Negative Sentiment: The key concern is that U.S. da Vinci procedure growth slowed to its lowest level since the COVID period. Investors worry that decelerating domestic demand could make it harder for Intuitive Surgical to sustain its premium valuation, which remains above 50 times earnings. Intuitive Surgical Sinks as U.S. da Vinci Growth Slows
• Negative Sentiment: RBC lowered its expectations for ISRG, and an analyst downgrade contributed to a gap lower in the shares. The market is emphasizing forward growth and valuation rather than the headline earnings beat. Intuitive Surgical Shares Gap Down Following Analyst Downgrade

Intuitive Surgical Stock Up 1.9%

Shares of Intuitive Surgical stock traded up $8.44 during trading hours on Friday, hitting $452.29. The company's stock had a trading volume of 3,004,340 shares, compared to its average volume of 2,247,738. The business has a fifty day moving average of $395.50 and a 200 day moving average of $409.13. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88. The company has a market capitalization of $156.78 billion, a PE ratio of 54.69, a P/E/G ratio of 3.31 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, beating the consensus estimate of $2.65 by $0.35. The business had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The business's quarterly revenue was up 21.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.40 EPS. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Mark Brosius sold 77 shares of the business's stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $375.57, for a total transaction of $28,918.89. Following the transaction, the executive vice president directly owned 881 shares of the company's stock, valued at approximately $330,877.17. The trade was a 8.04% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy Ladd sold 72 shares of the business's stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $393.10, for a total value of $28,303.20. Following the transaction, the director directly owned 179 shares in the company, valued at $70,364.90. This trade represents a 28.69% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 12,370 shares of company stock worth $4,891,989. Insiders own 0.60% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company's primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.